South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sandoz south africa (pty) ltd - capsules - see ingredients - each capsule contains omeprazole 20,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sandoz south africa (pty) ltd - injection - see ingredients - each vial contains meropenem trihydrate equivalent to meropenem 500,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sandoz south africa (pty) ltd - injection - see ingredients - each vial contains meropenem trihydrate equivalent to meropenem 1,0 g

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 169.8 mg (equivalent: venlafaxine, qty 150 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; sunset yellow fcf; povidone; magnesium stearate; microcrystalline cellulose; brilliant blue fcf; copovidone; allura red ac; purified talc; colloidal anhydrous silica; titanium dioxide; propylene glycol; ethanol; isopropyl alcohol; shellac; tert-butyl alcohol; sodium hydroxide - sandoz venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic pharmaceuticals australia pty ltd - venlafaxine hydrochloride, quantity: 84.9 mg (equivalent: venlafaxine, qty 75 mg) - capsule, modified release - excipient ingredients: iron oxide black; colloidal anhydrous silica; ethylcellulose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; titanium dioxide; gelatin; copovidone; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia - sandoz venlafaxine xr is indicated for the treatment of: - major depression, including prevention of relapse and recurrence where appropriate; - generalised anxiety disorder; - social anxiety disorder; panic disorder, including prevention of relapse.

Zimbabwe - English - Medicines Control Authority

sandoz s.a pty ltd - amoxycillin trihydrate; potassium clavulanate - tablet; oral - 875; 125mg

Zimbabwe - English - Medicines Control Authority

sandoz s.a pty ltd - amoxycillin trihydrate; potassium clavulanate - tablet; oral - 500; 125mg

Zimbabwe - English - Medicines Control Authority

sandoz s.a pty ltd - telmisartan - tablet; oral - 20mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for the temporary relief of acute moderate pain and inflammation in patients over the age of 12 years (see also contraindications and paediatric use)

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sandoz south africa (pty) ltd - tablet - see ingredients - each tablet contains amoxycillin trihydrate equivalent to amoxycillin 500,0 mg potassium clavulanate equivalent to clavulanic acid 125,0 mg